Eli Lilly's new shot shows solid weight loss in study — plus, a way for Nvidia to perk up

Eli Lilly's new weight-loss injection has demonstrated promising results in clinical studies, indicating its potential to significantly aid in obesity treatment. This development is crucial as it could enhance the company's position in the competitive pharmaceutical market. Additionally, Nvidia is exploring strategies to boost its performance, reflecting ongoing efforts to adapt in a rapidly changing tech landscape.